BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33436261)

  • 1. The antitumor role of a newly discovered α-d-glucan from Holotrichia diomphalia Bates as a selective blocker of aldolase A.
    Wang J; Li Z; Yang X; Qiao Y; Feng C; Yu S; Jing H; Liu W; Ren L; Duan Q; Li XQ; Cao W
    Carbohydr Polym; 2021 Mar; 255():117532. PubMed ID: 33436261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Glucan derivatives as selective blockers of aldolase A: Computer-aided structure optimization and the effects on HCC.
    Xiao QH; Li ZZ; Ren L; Wang SY; Li XQ; Bai HX; Qiao RZ; Tang N; Liu WJ; Wang JM; Ma GY; Dong DC; Wu KH; Cao W
    Carbohydr Polym; 2024 Feb; 325():121566. PubMed ID: 38008473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia.
    Niu Y; Lin Z; Wan A; Sun L; Yan S; Liang H; Zhan S; Chen D; Bu X; Liu P; Chen C; He W; Lu X; Wan G
    Hepatology; 2021 Sep; 74(3):1461-1479. PubMed ID: 33813748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldolase A promotes proliferation and G
    Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
    Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZNF692 drives malignant development of hepatocellular carcinoma cells by promoting ALDOA-dependent glycolysis.
    Meng W; Lu X; Wang G; Xiao Q; Gao J
    Funct Integr Genomics; 2024 Mar; 24(2):53. PubMed ID: 38453820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fructose-Bisphosphate Aldolase A Regulates Hypoxic Adaptation in Hepatocellular Carcinoma and Involved with Tumor Malignancy.
    Li X; Jiang F; Ge Z; Chen B; Yu J; Xin M; Wang J; An L; Wei J; Wu L
    Dig Dis Sci; 2019 Nov; 64(11):3215-3227. PubMed ID: 31041640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MKL-1-induced PINK1-AS overexpression contributes to the malignant progression of hepatocellular carcinoma via ALDOA-mediated glycolysis.
    Wang J; Zhang HM; Dai ZT; Huang Y; Liu H; Chen Z; Wu Y; Liao XH
    Sci Rep; 2022 Dec; 12(1):21283. PubMed ID: 36494481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer.
    Jiang Z; Wang X; Li J; Yang H; Lin X
    J Cell Mol Med; 2018 Sep; 22(9):4377-4386. PubMed ID: 29992789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of the ALDOA/DNA-PK/p53 pathway by dietary restriction suppresses tumor growth.
    Ma D; Chen X; Zhang PY; Zhang H; Wei LJ; Hu S; Tang JZ; Zhou MT; Xie C; Ou R; Xu Y; Tang KF
    Oncogene; 2018 Feb; 37(8):1041-1048. PubMed ID: 29084207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2.
    Xu D; Jin J; Yu H; Zhao Z; Ma D; Zhang C; Jiang H
    J Exp Clin Cancer Res; 2017 Mar; 36(1):44. PubMed ID: 28320429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Targeting of Aldolase A Interactions Inhibits Lung Cancer Metastasis and Prolongs Survival.
    Chang YC; Chiou J; Yang YF; Su CY; Lin YF; Yang CN; Lu PJ; Huang MS; Yang CJ; Hsiao M
    Cancer Res; 2019 Sep; 79(18):4754-4766. PubMed ID: 31358528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldolase A Enhances Intrahepatic Cholangiocarcinoma Proliferation and Invasion through Promoting Glycolysis.
    Li X; Yu C; Luo Y; Lin J; Wang F; Sun X; Gao Y; Tan W; Xia Q; Kong X
    Int J Biol Sci; 2021; 17(7):1782-1794. PubMed ID: 33994862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting a moonlighting function of aldolase induces apoptosis in cancer cells.
    Gizak A; Wiśniewski J; Heron P; Mamczur P; Sygusch J; Rakus D
    Cell Death Dis; 2019 Sep; 10(10):712. PubMed ID: 31558701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldolase A promotes cervical cancer cell radioresistance by regulating the glycolysis and DNA damage after irradiation.
    Zhou J; Lei N; Qin B; Chen M; Gong S; Sun H; Qiu L; Wu F; Guo R; Ma Q; Li Y; Chang L
    Cancer Biol Ther; 2023 Dec; 24(1):2287128. PubMed ID: 38010897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment.
    Cassim S; Raymond VA; Dehbidi-Assadzadeh L; Lapierre P; Bilodeau M
    Cell Cycle; 2018; 17(7):903-916. PubMed ID: 29633904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
    Kawai K; Uemura M; Munakata K; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2017 Feb; 50(2):525-534. PubMed ID: 28000858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of fructose-bisphosphate aldolase A induces progression of renal cell carcinoma.
    Huang Z; Hua Y; Tian Y; Qin C; Qian J; Bao M; Liu Y; Wang S; Cao Q; Ju X; Wang Z; Gu M
    Oncol Rep; 2018 Jun; 39(6):2996-3006. PubMed ID: 29693182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of fructose 1,6-bisphosphate-mediated glycolysis/gluconeogenesis genes in cancer prognosis.
    Li CH; Chan MH; Chang YC
    Aging (Albany NY); 2022 Apr; 14(7):3233-3258. PubMed ID: 35404841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-122-5p Inhibits the Proliferation, Invasion and Growth of Bile Duct Carcinoma Cells by Targeting ALDOA.
    Xu Z; Liu G; Zhang M; Zhang Z; Jia Y; Peng L; Zhu Y; Hu J; Huang R; Sun X
    Cell Physiol Biochem; 2018; 48(6):2596-2606. PubMed ID: 30121648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonenzymatic function of Aldolase A downregulates miR-145 to promote the Oct4/DUSP4/TRAF4 axis and the acquisition of lung cancer stemness.
    Chang YC; Yang YF; Chiou J; Tsai HF; Fang CY; Yang CJ; Chen CL; Hsiao M
    Cell Death Dis; 2020 Mar; 11(3):195. PubMed ID: 32188842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.